Palladyne AI Corp. (PDYN)
USD 3.61
(1.98%)
USD 3.61
(1.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 6.14 Million | 14.56 Million | 5.07 Million | 8.81 Million |
| Cost of Revenue | 5.04 Million | 11.61 Million | 3.86 Million | 5.6 Million |
| Gross Profit | 1.1 Million | 2.95 Million | 1.2 Million | 3.21 Million |
| Operating Expenses | 84.11 Million | 109.75 Million | 82.19 Million | 24.21 Million |
| Selling, General and Administrative Expenses | 42.28 Million | 73.42 Million | 64.68 Million | 10.09 Million |
| Research and Development Expenses | 39.01 Million | 34.14 Million | 17.51 Million | 14.11 Million |
| Other Expenses | 2.82 Million | 743 Thousand | 51 Thousand | 34 Thousand |
| Cost and Expenses | 127.1 Million | 121.37 Million | 86.06 Million | 29.81 Million |
| Operating Income | -83.01 Million | -177.03 Million | -80.99 Million | -20.99 Million |
| Interest Expense | - | - | 34 Thousand | - |
| Income Tax Expense | 7000.00 | -3.89 Million | 1000.00 | 1000.00 |
| Earnings before Tax | -115.58 Million | -161.02 Million | -81.5 Million | -20.92 Million |
| Net Income | -115.59 Million | -157.13 Million | -81.5 Million | -20.92 Million |
| Earnings Per Share Basic | -4.51 | -6.42 | -4.32 | -1.21 |
| Earnings Per Share Diluted | -4.51 | -6.42 | -4.32 | -1.21 |
| Weighted Average Shares Outstanding | 25.63 Million | 24.47 Million | 18.86 Million | 17.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.63 Million | 24.47 Million | 18.86 Million | 17.34 Million |
| Gross Margin | 0.18 | 0.20 | 0.24 | 0.36 |
| EBIT Margin | -12.79 | -3.19 | -15.75 | -2.33 |
| Profit Margin | -18.81 | -10.79 | -16.06 | -2.37 |
| EBITDA | -78.63 Million | -103.2 Million | -80.46 Million | -20.54 Million |
| Earnings Before Tax Margin | -13.51 | -12.15 | -15.96 | -2.38 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.71 Million | 3.44 Million | 6.14 Million | 746 Thousand | 1.82 Million | 1.27 Million |
| Cost of Revenue | 569 Thousand | 1.88 Million | 5.04 Million | 1.09 Million | 1.22 Million | 943 Thousand |
| Gross Profit | 2.14 Million | 1.55 Million | 1.1 Million | -344 Thousand | 605 Thousand | 334 Thousand |
| Operating Expenses | 8.01 Million | 8.82 Million | 84.11 Million | 15.09 Million | 20.13 Million | 25.18 Million |
| Selling, General and Administrative Expenses | 5.67 Million | 5.93 Million | - | 6.83 Million | 9.3 Million | 12.66 Million |
| Research and Development Expenses | 2.34 Million | 2.89 Million | - | 7.89 Million | 10.01 Million | 11.7 Million |
| Other Expenses | 2000.00 | - | 1.91 Million | 5000.00 | 871 Thousand | -11 Thousand |
| Cost and Expenses | 8.58 Million | 10.71 Million | 89.15 Million | 16.18 Million | 21.35 Million | 26.13 Million |
| Operating Income | -5.87 Million | -7.27 Million | -120.95 Million | -37.05 Million | -30.75 Million | -29.95 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | 157.72 Thousand | 7000.00 | 4000.00 | 10.32 Million | 3000.00 |
| Earnings before Tax | -5.32 Million | -7.22 Million | -115.58 Million | -36.47 Million | -28.98 Million | -28.65 Million |
| Net Income | -5.32 Million | -7.22 Million | -115.59 Million | -36.47 Million | -28.98 Million | -28.66 Million |
| Earnings Per Share Basic | -0.20 | -0.28 | - | -1.41 | -1.13 | -1.12 |
| Earnings Per Share Diluted | -0.20 | -0.28 | - | -1.41 | -1.13 | -1.12 |
| Weighted Average Shares Outstanding | 26.62 Million | 25.87 Million | 25.63 Million | 25.87 Million | 25.7 Million | 25.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.62 Million | 25.87 Million | 25.63 Million | 25.87 Million | 25.7 Million | 25.51 Million |
| Gross Margin | 0.79 | 0.45 | 0.18 | -0.46 | 0.33 | 0.26 |
| EBIT Margin | -2.09 | -2.05 | - | 9.08 | -3.92 | -14.84 |
| Profit Margin | -1.96 | -2.10 | -18.81 | -48.90 | -15.86 | -22.44 |
| EBITDA | -5.67 Million | -7.06 Million | - | 6.77 Million | -7.16 Million | -18.94 Million |
| Earnings Before Tax Margin | -2.17 | -2.11 | -19.68 | -49.67 | -16.83 | -23.46 |
SVM
INEOF
USAP
PRINCEPIPE
FASTAT
DBREALTY